Lindbrook Capital, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 570 shares of ALNY stock, worth $157,057. This represents 0.01% of its overall portfolio holdings.

Number of Shares

570

Previous 513 11.11%

Holding current value

$157,057

Previous $124,000 25.81%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$233.81 - $287.01 $13,327 - $16,359	57 Added 11.11%	570 $156,000
Q2 2024 Jul 31, 2024	BUY	$143.31 - $247.0 $39,696 - $68,419	277 Added 117.37%	513 $124,000
Q1 2024 Apr 25, 2024	SELL	$146.51 - $198.2 $19,485 - $26,360	-133 Reduced 36.04%	236 $35,000
Q4 2023 Jan 31, 2024	BUY	$151.41 - $196.57 $15,141 - $19,657	100 Added 37.17%	369 $70,000
Q3 2023 Oct 25, 2023	BUY	$170.77 - $211.65 $3,756 - $4,656	22 Added 8.91%	269 $47,000
Q2 2023 Jul 28, 2023	BUY	$185.01 - $212.05 $8,325 - $9,542	45 Added 22.28%	247 $46,000
Q1 2023 Apr 26, 2023	SELL	$182.66 - $235.53 $9,863 - $12,718	-54 Reduced 21.09%	202 $40,000
Q4 2022 Jan 24, 2023	BUY	$185.53 - $241.31 $7,606 - $9,893	41 Added 19.07%	256 $0
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $6,372 - $10,672	46 Added 27.22%	215 $43,000
Q2 2022 Aug 01, 2022	BUY	$120.42 - $169.29 $361 - $507	3 Added 1.81%	169 $25,000
Q1 2022 Apr 21, 2022	SELL	$127.18 - $173.91 $2,162 - $2,956	-17 Reduced 9.29%	166 $27,000
Q4 2021 Jan 18, 2022	SELL	$159.56 - $209.29 $478 - $627	-3 Reduced 1.61%	183 $31,000
Q3 2021 Nov 05, 2021	BUY	$169.75 - $207.73 $2,206 - $2,700	13 Added 7.51%	186 $35,000
Q2 2021 Jul 27, 2021	SELL	$128.63 - $176.89 $1,029 - $1,415	-8 Reduced 4.42%	173 $29,000
Q1 2021 Apr 28, 2021	BUY	$126.83 - $175.69 $1,902 - $2,635	15 Added 9.04%	181 $26,000
Q4 2020 Jan 27, 2021	BUY	$122.97 - $147.0 $614 - $735	5 Added 3.11%	166 $22,000
Q3 2020 Nov 03, 2020	BUY	$121.19 - $165.49 $12,361 - $16,879	102 Added 172.88%	161 $23,000
Q2 2020 Jul 27, 2020	BUY	$104.21 - $156.44 $729 - $1,095	7 Added 13.46%	59 $9,000
Q1 2020 Apr 22, 2020	BUY	$93.12 - $133.99 $4,842 - $6,967	52 New	52 $6,000

Others Institutions Holding ALNY

# of Institutions

647

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.22M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Alnylam Pharmaceuticals, Inc. Transaction History